Status:
RECRUITING
A Prediction Model in Pregnant Women With Aplastic Anemia
Lead Sponsor:
Peking University People's Hospital
Collaborating Sponsors:
Tianjin Medical University General Hospital
Lanzhou University Second Hospital
Conditions:
Aplastic Anemia
Pregnancy
Eligibility:
FEMALE
20-50 years
Brief Summary
Aplastic anemia (AA) is a rare haematologic disorder characterized by bone marrow failure and pancytopenia. Its occurrence during pregnancy is exceedingly rare but poses significant risks, including m...
Detailed Description
The gestational period, a physiological condition linked to elevated physiological stress, induces significant cardiac remodeling and systemic hemodynamic adaptations in maternal organisms. AA, a rare...
Eligibility Criteria
Inclusion Criteria:
- pregnant women who had aplastic anemia before pregnancy
- pregnant women with newly diagnosed aplastic anemia during pregnancy
Exclusion Criteria:
- age less than 20 years
- without coagulation series results
- termination of pregnancy before 20 weeks of gestation
- multiple pregnancy
Key Trial Info
Start Date :
November 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07101770
Start Date
November 27 2025
End Date
December 31 2030
Last Update
December 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, China, 100044